维普期刊资源整合服务平台（V6.5）

149篇 您的检索式：作者名="Stoehlmacher"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial显示文摘	Gunnar Folprecht Thomas Gruenberger Wolf O Bechstein Hans-Rudolf Raab Florian Lordick J?rg T Hartmann Hauke Lang Andrea Frilling Jan Stoehlmacher Jürgen Weitz Ralf Konopke Christian Stroszczynski Torsten Liersch Detlev Ockert Thomas Herrmann Eray Goekkurt	2010	Lancet Oncology2010，，1：	3
2	A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity 显示文摘	MANDOLA M V STOEHLMACHER J MULLER-WEEKS S	2003	Cancer Res2003，63，1：	1
3	Thymidylate synthase gene polymorphism determines response and toxicity of 5-Fu chemotherapy显示文摘	PullarkatST Stoehlmacher J Ghaderi V	2001	Pharmacogenomies J2001，1，1：	1
4	A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer显示文摘	Stoehlmacher J Ghaderi V Iobal S	2001	Anticancer Res2001，21，4：	1
5	Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer显示文摘	David J. Park Jan Stoehlmacher Wu Zhang Denice Tsao-Wei Susan Groshen Heinz-Josef Lenz	2001	International Journal of Colorectal Disease2001，，1：	1
6	Thymidylate synthaae gene polymorphism determines response and toxicity of 5-FU chemotherapy显示文摘	Pullarkat ST Stoehlmacher J Ghaderi V Xiang YP Ingles SA Sherrod A	2001	Pharmacogenomies J2001，1，1：	1
7	A novel single nucleotide polymorphism within the 5 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF1 binding and alters transcriptional activity显示文摘	Mandola MV Stoehlmacher J Muller-Weeks S	2003	Cancer Ras2003，63，11：	1
8	ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil Chemotherapy 显示文摘	Shirota Y Stoehlmacher J Brabender J	2001	Clin Oneol2001，19，23：	1
9	A novel single nueleotide polymorphism within the 5r tandem repeat polymorphism of the thymidylate synthase gene abolishes USF 1 binding and alters transcriptional activity 显示文摘	Mandola MV Stoehlmacher J Muller-Weeks S	2003	Cancer Res2003，63，11：	1
10	A 6bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumor TS mRNA levels显示文摘	MANDOLA M V STOEHLMACHER J ZHANG W	2004	Pharmacogenetics2004，14，5：	1
11	ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy显示文摘	SHIROTA Y STOEHLMACHER J BRABENDER J	2001	Clin Oncol2001，19，23：	1
12	A novel single nucleotide polymorphism within the 5 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF1 binding and alters transcriptional activity显示文摘	Mandola MV Stoehlmacher J Muller-Weeks S	2003	Cancer Ras2003，63，11：	1
13	A xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer显示文摘	Park DJ Stoehlmacher J Zhang W	2001	Cancer Res2001，61，24：	1
14	ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination ox- aliplatin and fluorouracil chemotherapy 显示文摘	Shirota Y Stoehlmacher J Brabender J	2001	J Clini On- col2001，19，23：	1
15	ERCC1 genetic polymorphisms as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy 显示文摘	Park D J Zhang W Stoehlmacher J	2003	Clin Adv Hematol Oncol2003，1，3：	1
16	ERCC1 andthymidylate synthase mRNA levels predict survival forcolorectal cancer patients receiving combination oxaliplatinand fluorouracil chemotherapy显示文摘	Shirota Y Stoehlmacher J Brabender J	2001	J Clin Oncol2001，19，23：	1
17	ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy显示文摘	Shirota Y Stoehlmacher J Brabender J	2001	J Clin Oncol2001，19，5：	1
18	ERCC1 and thymidylate synthase mRNA levels predict survival for coloectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy显示文摘	Shirota Y Stoehlmacher J Brabender J	2001	J Clin Oncol2001，19，23：	1
19	A multivariate analysis of genomic polymorphisms:prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer 显示文摘	Stoehlmacher J Park DJ Zhang W	2004	Br J Cancer2004，91，2：	1
20	ERCCl and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy显示文摘	Shirota Y Stoehlmacher J Brabender J	2001	J Clin Oncol2001，19，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示